We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Johnson Matthey, Domainex Collaborate

News   Apr 19, 2016

 
Johnson Matthey, Domainex Collaborate
 
 
Advertisement
 

RELATED ARTICLES

Computer Model Finds the Right Balance for Parkinson's Medication

News

As Parkinson's disease progresses, more levodopa is required to treat it. Too much, however, can lead to uncontrollable, involuntary bodily movements. To better understand the underlying reasons behind these effects, researchers created a model of the interactions between levodopa, dopamine, and the brain.

READ MORE

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE